Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0106 | 0.0295 | 0.0288 |
Toxoplasma gondii | exonuclease III APE | 0.0022 | 0.0019 | 0.0019 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0078 | 0.0201 | 0.0201 |
Echinococcus granulosus | Alpha N acetylgalactosaminidase | 0.0116 | 0.0329 | 0.0321 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0022 | 0.0019 | 1 |
Schistosoma mansoni | fructose-16-bisphosphatase-related | 0.3056 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0022 | 0.0019 | 0.0019 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0022 | 0.0019 | 0.0011 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.0027 | 0.0027 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0022 | 0.0019 | 0.0011 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0022 | 0.0019 | 0.056 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0044 | 0.009 | 0.0082 |
Echinococcus multilocularis | dna polymerase eta | 0.0044 | 0.009 | 0.0082 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0022 | 0.0019 | 0.0011 |
Echinococcus granulosus | fructose 16 bisphosphatase 1 | 0.3056 | 1 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0022 | 0.0019 | 0.0011 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.3056 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0106 | 0.0295 | 0.0295 |
Toxoplasma gondii | fructose-bisphospatase II | 0.3056 | 1 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0027 | 0.0019 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0022 | 0.0019 | 0.0011 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0044 | 0.009 | 0.0082 |
Trypanosoma cruzi | sedoheptulose-1,7-bisphosphatase, putative | 0.1136 | 0.3685 | 0.368 |
Leishmania major | DNA polymerase eta, putative | 0.0044 | 0.009 | 0.0082 |
Schistosoma mansoni | DNA polymerase eta | 0.0044 | 0.009 | 0.009 |
Trichomonas vaginalis | alpha-galactosidase/alpha-N-acetylgalactosaminidase, putative | 0.0078 | 0.0201 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.009 | 0.0082 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0116 | 0.0329 | 0.0329 |
Echinococcus granulosus | dna polymerase eta | 0.0044 | 0.009 | 0.0082 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0022 | 0.0019 | 0.0011 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0022 | 0.0019 | 0.0011 |
Trypanosoma brucei | sedoheptulose-1,7-bisphosphatase | 0.1136 | 0.3685 | 0.368 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0022 | 0.0019 | 0.056 |
Toxoplasma gondii | fructose-bisphospatase I | 0.1136 | 0.3685 | 0.3685 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0019 | 0.0008 | 0.0008 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.0027 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0106 | 0.0295 | 0.0295 |
Echinococcus multilocularis | Alpha N acetylgalactosaminidase | 0.0116 | 0.0329 | 0.0321 |
Echinococcus multilocularis | fructose 1,6 bisphosphatase 1 | 0.3056 | 1 | 1 |
Loa Loa (eye worm) | fructose-1,6-bisphosphatase | 0.3056 | 1 | 1 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0921 | 0.2976 | 0.2971 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0027 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0106 | 0.0295 | 0.0288 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0106 | 0.0295 | 0.0288 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0022 | 0.0019 | 1 |
Trypanosoma cruzi | sedoheptulose-1,7-bisphosphatase, putative | 0.1136 | 0.3685 | 0.368 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.0027 | 0.0019 |
Toxoplasma gondii | sedoheptulose-1,7-bisphosphatase | 0.1136 | 0.3685 | 0.3685 |
Brugia malayi | Melibiase family protein | 0.0078 | 0.0201 | 0.0193 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0116 | 0.0329 | 0.0329 |
Brugia malayi | hypothetical protein | 0.0025 | 0.0027 | 0.0019 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0106 | 0.0295 | 0.0295 |
Trypanosoma brucei | fructose-1,6-bisphosphatase | 0.3056 | 1 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0027 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0031 | 0.0047 | 0.0039 |
Leishmania major | 0.3056 | 1 | 1 | |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0022 | 0.0019 | 1 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0044 | 0.009 | 0.0082 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0116 | 0.0329 | 0.0329 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0078 | 0.0201 | 0.0201 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0022 | 0.0019 | 0.0011 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0027 | 0.0019 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.3056 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0022 | 0.0019 | 0.5 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0022 | 0.0019 | 0.5 |
Echinococcus multilocularis | Glycoside hydrolase, family 27 | 0.0116 | 0.0329 | 0.0321 |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0.0201 | 0.0193 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0027 | 0.0019 |
Schistosoma mansoni | ap endonuclease | 0.0022 | 0.0019 | 0.0019 |
Leishmania major | DNA polymerase eta, putative | 0.0031 | 0.0047 | 0.0039 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.0027 | 0.0019 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0106 | 0.0295 | 0.0288 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0106 | 0.0295 | 0.0288 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0116 | 0.0329 | 0.0329 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0022 | 0.0019 | 1 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0031 | 0.0047 | 0.0047 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0106 | 0.0295 | 0.0288 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0019 | 0.0008 | 0.0008 |
Toxoplasma gondii | melibiase subfamily protein | 0.0116 | 0.0329 | 0.0329 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | > 10 ug ml-1 | Cytotoxicity against human MCF7 cells assessed as cell growth after 2 days by sulforhodamine B assay | ChEMBL. | 21481593 |
GI50 (functional) | > 10 ug ml-1 | Cytotoxicity against human H460 cells assessed as cell growth after 2 days by sulforhodamine B assay | ChEMBL. | 21481593 |
GI50 (functional) | > 10 ug ml-1 | Cytotoxicity against human SF268 cells assessed as cell growth after 2 days by sulforhodamine B assay | ChEMBL. | 21481593 |
MFC (functional) | = 62.5 ug ml-1 | Antifungal activity against Saccharomyces cerevisiae ATCC 9763 | ChEMBL. | 21481593 |
MFC (functional) | = 62.5 ug ml-1 | Antifungal activity against Cryptococcus neoformans ATCC 32264 | ChEMBL. | 21481593 |
MFC (functional) | = 125 ug ml-1 | Antifungal activity against Candida albicans ATCC 10213 | ChEMBL. | 21481593 |
MIC (functional) | = 31.25 ug ml-1 | Antifungal activity against Saccharomyces cerevisiae ATCC 9763 | ChEMBL. | 21481593 |
MIC (functional) | = 31.25 ug ml-1 | Antifungal activity against Cryptococcus neoformans ATCC 32264 | ChEMBL. | 21481593 |
MIC (functional) | = 62.5 ug ml-1 | Antifungal activity against Candida albicans ATCC 10213 | ChEMBL. | 21481593 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.